Yahoo Web Search

Search results

1. • 

     FDA Approves Skyrizi for Ulcerative Colitis

     Medscape· 1 day ago

     The approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...

2. • Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of “Moderate Buy” by Analysts

     ETF DAILY NEWS· 14 hours ago

     Amgen Inc. (NASDAQ:AMGN – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are presently covering the stock, Marketbeat Ratings ...

3. • Johnson & Johnson (NYSE:JNJ) Shares Bought by Davis Capital Management

     ETF DAILY NEWS· 7 hours ago

     Davis Capital Management boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange ...

4. • Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)

     ETF DAILY NEWS· 6 hours ago

     Bath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities ...

5. • Reviva Pharmaceuticals (NASDAQ:RVPH) Given Buy Rating at HC Wainwright

     ETF DAILY NEWS· 8 hours ago

     Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They presently ...

6. • AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC

     ETF DAILY NEWS· 6 hours ago

     Carolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the Securities ...

7. • Pensionfund Sabic Sells 3,100 Shares of AbbVie Inc. (NYSE:ABBV)

     ETF DAILY NEWS· 6 hours ago

     Pensionfund Sabic lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 15.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The ...

8. • In a 'gold rush' for treating bowel disease, AbbVie clears one more stage

     Crain s Chicago Business· 21 hours ago

     With the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...

9. • Johnson & Johnson (NYSE:JNJ) Shares Sold by Capital Market Strategies LLC

     ETF DAILY NEWS· 8 hours ago

     Capital Market Strategies LLC reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.4% in the 1st quarter, according to the company in its most recent disclosure ...

10. • 

      Why Is My Skin So Itchy?

      Verywell Health via Yahoo News· 2 days ago

      Pruritus, or itchy skin, is a characteristic feature of many skin diseases and an unusual sign of some systemic diseases. It can be painful or...